Bonnem E - Search Results

1

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.

Steward WP, Scarffe JH, Austin R, Bonnem E, Thatcher N, Morgenstern G, Crowther D. Steward WP, et al. Among authors: bonnem e. Br J Cancer. 1989 Jan;59(1):142-5. doi: 10.1038/bjc.1989.28. Br J Cancer. 1989. PMID: 2667607 Free PMC article.

2

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial.

Gilleece MH, Scarffe JH, Ghosh A, Heyworth CM, Bonnem E, Testa N, Stern P, Dexter TM. Gilleece MH, et al. Among authors: bonnem e. Br J Cancer. 1992 Jul;66(1):204-10. doi: 10.1038/bjc.1992.243. Br J Cancer. 1992. PMID: 1637669 Free PMC article. Clinical Trial.

3

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.

Steward WP, Scarffe JH, Dirix LY, Chang J, Radford JA, Bonnem E, Crowther D. Steward WP, et al. Among authors: bonnem e. Br J Cancer. 1990 May;61(5):749-54. doi: 10.1038/bjc.1990.167. Br J Cancer. 1990. PMID: 1692472 Free PMC article.

4

Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.

Steward WP, Scarffe JH, Bonnem E, Crowther D. Steward WP, et al. Among authors: bonnem e. Int J Cell Cloning. 1990 Jan;8 Suppl 1:335-46. doi: 10.1002/stem.5530080731. Int J Cell Cloning. 1990. PMID: 2182743 Free article.

5

Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM, et al. Lieschke GJ, et al. Among authors: bonnem e. Cancer Res. 1990 Feb 1;50(3):606-14. Cancer Res. 1990. PMID: 2404573

6

High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma.

Barlogie B, Jagannath S, Dixon DO, Cheson B, Smallwood L, Hendrickson A, Purvis JD, Bonnem E, Alexanian R. Barlogie B, et al. Among authors: bonnem e. Blood. 1990 Aug 15;76(4):677-80. Blood. 1990. PMID: 2200536 Free article.

7

Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.

Lieschke GJ, Maher D, Cebon J, O'Connor M, Green M, Sheridan W, Boyd A, Rallings M, Bonnem E, Metcalf D, et al. Lieschke GJ, et al. Among authors: bonnem e. Ann Intern Med. 1989 Mar 1;110(5):357-64. doi: 10.7326/0003-4819-110-5-357. Ann Intern Med. 1989. PMID: 2644886

8

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.

Thompson JA, Lee DJ, Kidd P, Rubin E, Kaufmann J, Bonnem EM, Fefer A. Thompson JA, et al. Among authors: bonnem em. J Clin Oncol. 1989 May;7(5):629-37. doi: 10.1200/JCO.1989.7.5.629. J Clin Oncol. 1989. PMID: 2651578

9

Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay.

Cebon J, Dempsey P, Fox R, Kannourakis G, Bonnem E, Burgess AW, Morstyn G. Cebon J, et al. Among authors: bonnem e. Blood. 1988 Oct;72(4):1340-7. Blood. 1988. PMID: 3048442 Free article.

10

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.

Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, Fleming NC, Bonnem EM, Greenberg PL. Advani R, et al. Among authors: bonnem em. Ann Intern Med. 1992 Feb 1;116(3):183-9. doi: 10.7326/0003-4819-116-3-183. Ann Intern Med. 1992. PMID: 1345803 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters